drugset / Trial / NCT02065167

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip

NCT02065167 ↗

Phase 2 Completed 26 enrolled Universidad Autonoma de Madrid
NaSingle-groupOpen-labelTreatment

Summary

The purpose is to assess the safety and feasibility of cellular therapy derived from bone marrow, to help bone healing in patients with avascular necrosis of the hip.

Timeline

Start
2014-02
Primary completion
2016-06
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cultured autologous Mesenchymal Cells Cell therapy 1.4e+08 cells Other

Indications